Ocata publishes Phase 2 trial protocol!!

Here it is!! On clinicaltrials.gov!! YES and YAY. We are getting closer and closer to a cure for the most common cause of blindness in the developed world. There’s only one possible response to this… make a pumpkin pie! 🙂 (Oh, okay, I was already going to do that anyway…) But I’ll let you know how it turned out. For a truly excellent article explaining what this means, I’ll send you to the one and only Dr. Hartman’s (aka Deadally’s) analysis on Seeking Alpha:
Ocata Therapeutics Is An Official Phase 2 Biotech: AMD Efficacy Study Design Details

And here’s a comment I just left on the article:

Thanks so much for this excellent article, Dr. Hartman! 🙂 So many people could be helped this way. And as I know all too well… NOT everyone who has some form of MD is ninety years old. I’m certainly not, but it does get worse than that. Every time I’ve been at Casey Eye Institute, I’ve seen small children with Stargardt’s. It’s one of the saddest sights you could ever imagine. I know I’ll never forget the time I saw a baby with bandages over its face being wheeled down the hall in a huge cot enclosed by bars. What Ocata is doing will ultimately provide the opportunity to save people of all ages from blindness.

Cathy Danielson
Follow me!

Cathy Danielson

In 2011, my life was shattered when I was diagnosed with a mysterious, incurable disease that always ends in blindness. The only hope on the horizon was a drug that broke all barriers in early testing. This drug, which replaces damaged cells in the eye, comes from the new class of stem cell based treatments that could cure the incurable, providing hope for patients with cancer, heart failure, ALS, cerebral palsy, and many more fatal and disabling diseases.

I survived the disease, and I now have the only remission on record. But a remission is not a cure. The stem cell drug I need for a real cure is now rapidly moving towards approval in the rest of the world, but in the USA, it—and all other cellular therapies-- are still stuck behind prejudice, ignorance, and lack of funding. Hundreds of millions of desperate patients with incurable diseases need these drugs.

That’s why I’ve gone on to fight for greater public education on stem cell drugs, knowing that our laws must be changed so that all of us can get access to the best treatments instead of our health and our lives being held hostage by special interests.

I’m now a patient advocate whose work on stem cells and patients’ rights has been published in outlets such as the Oregonian. I am a manager at popular science and financial blog www.stemcellinvestor.com and a frequent speaker at many venues across the spectrum, including churches, scientific conferences, and atheist groups, and everything in between. I’m also an advocate for Right to Try laws that would allow access to experimental medication for terminal patients at the state level. Read the entire story in my upcoming book, And the Blind Shall See: A Skeptic Patient Surprised by Faith, Science, Family, and Miracle Cures.
Cathy Danielson
Follow me!

Leave a Reply

Your email address will not be published. Required fields are marked *